Project Grant R21TW012988
Award Date
9/1/24
Completion Date
7/31/26
Dollars Obligated
$347K
Federal Agency
Fogarty International Center
Federal Grant Program
93.989
Assistance Type
Project Grant
Place of Performance
Uganda
Similar Awards
This Project Grant award for $665,171.00, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to improve outcomes for individuals with HIV-associated opportunistic infections like cryptococcal and TB meningitis. The key objectives are to: 1) define CSF drug concentrations or AUC/MIC ratios that predict fungal clearance, 2) determine the relationship between...
The U.S. Department of Health and Human Services, through the Fogarty International Center's International Research and Research Training program (CFDA 93.989), awarded a $749,200 Project Grant to the Regents of the University of Minnesota. This 5-year grant, effective August 14, 2024, supports the Minnesota-Makerere-Mbarara Neuro-Infectious Disease Research Training Consortium in Uganda. The program aims to expand research expertise in neuro-infectious diseases by training at least 12 physician...
This Project Grant award, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), supports a comprehensive study to determine the prevalence and clinical characteristics of mild cognitive impairment (MCI) and Alzheimer's-related dementia (ADRD) among older adults living with HIV in Uganda. The $1,103,953 award, which began on Sep 15, 2024 and runs through Aug 31, 2025, will fund the following key activities: Comprehensive neuropsychological assessments among 600 older...
This federal Project Grant award of $232,073.00, provided by the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research Program (CFDA 93.855), supports research to investigate the dynamics between the fungal pathogen Cryptococcus neoformans (CN) and microglia cells in the context of HIV co-infection. The research aims to explore the impact of CN's replicative aging on its survival and virulence within the host, particularly in the cerebrospinal...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $515,875 over approximately 5 years to the University of Florida to conduct research on the mechanisms underlying Cryptococcus neoformans-induced meningoencephalitis and neurotoxicity in a CD4 T cell-deficient mouse model. The key objectives are to: (1) determine how the Cryptococcus neoformans capsular...
The National Institutes of Health (NIH) Fogarty International Center (CFDA 93.989) awarded a $361,922 Project Grant to Makerere University College of Health Sciences in Uganda to establish a registry and research platform focused on the intersection of HIV and rheumatic/musculoskeletal diseases (RMDs). The 2-year project aims to collect epidemiological and clinical data on patients with co-morbid HIV and RMDs, in order to advance research on this important but underrecognized issue in...
The Fogarty International Center (FIC), part of the U.S. Department of Health and Human Services National Institutes of Health, awarded a $268,665 Project Grant (CFDA 93.989 - International Research and Research Training) to the Joint Clinical Research Centre in Uganda. The grant, titled "LEVERAGING NORTH-SOUTH PARTNERSHIPS TO ADVANCE CELL AND GENE THERAPY FOR HIV RESEARCH TRAINING CAPACITY IN UGANDA (C AND GT-UGANDA)," aims to build research and training capacity for cell and gene...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $215,860 to the Regents of the University of Minnesota to support a mid-career investigator's research focused on improving the diagnosis, treatment, and prevention of neuro-infections, particularly HIV-related cryptococcal and tuberculosis meningitis. The key products and services to be delivered through this 5-year...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is providing $239,490.00 to the Regents of the University of Minnesota to conduct research focused on the impact of cytomegalovirus (CMV) viremia on opportunistic neuroinfections in advanced HIV disease. The objective of this 5-year award, which began on September 18, 2024, is to...
This $100,720 Project Grant awarded by the Fogarty International Center (CFDA 93.989 - International Research and Research Training) aims to strengthen the capacity of the African Center of Excellence in Bioinformatics and Data Intensive Sciences (ACE) in Uganda to support HIV research. The grant will fund the training of four local staff in high-performance computing (HPC) competencies at the Texas Advanced Computing Center, enabling them to implement HPC system improvements and integrate HPC...